The Reddit thread highlights a pilot navigating the FAA's certification pathway for airmen using sertraline, one of four SSRIs (selective serotonin reuptake inhibitors) the agency has authorized for special issuance since 2010, alongside citalopram, escitalopram, and fluoxetine. The original poster has been stable on sertraline for seven months and was advised by their Aviation Medical Examiner (AME) to bring comprehensive progress notes related to the depression diagnosis to support the medical certificate application. This scenario reflects the FAA's structured but often lengthy process for airmen seeking certification while on mental health medication, which typically requires documentation of at least six months of stability on the medication before an AME can even consider forwarding the case, and often involves additional psychiatric evaluations, cognitive screening, and a HIMS (Human Intervention Motivation Study) AME's involvement depending on the certificate class sought.
For working pilots, this topic carries significant weight because mental health certification remains one of the most opaque and anxiety-inducing aspects of maintaining medical currency. Since the FAA's 2010 policy change allowing SSRIs under special issuance, thousands of pilots have successfully returned to the cockpit, but the process is notoriously inconsistent in timeline—ranging from a few months to over a year—depending on the Aerospace Medical Certification Division's caseload, the completeness of submitted paperwork, and whether follow-up requests for additional records or evaluations arise. For Class 1 applicants specifically (airline transport pilots), the scrutiny is often heightened given the safety-critical nature of commercial operations, and the FAA may require more extensive documentation than for Class 2 or 3 applicants. Pilots considering this pathway often benefit from working with an AME experienced in mental health special issuances or a HIMS-trained AME, since general practitioners unfamiliar with FAA-specific documentation requirements can inadvertently slow the process by submitting incomplete records.
This case also underscores a broader industry conversation about pilot mental health that has intensified following high-profile incidents—including the 2023 case of an off-duty pilot attempting to shut down engines mid-flight, which was later linked to undisclosed psychedelic use and untreated mental health issues—and the ongoing pilot shortage that has made retention and return-to-work pathways for medically grounded aviators more consequential. The FAA, along with organizations like the Aviation Medicine Advisory Service (AMAS) and various pilot unions, has faced pressure to modernize and expedite mental health certification, recognizing that stigma and fear of career-ending medical denial often discourage pilots from seeking treatment altogether. Advocacy groups and researchers have pushed for reforms similar to those adopted by EASA and other international regulators, which in some cases allow more streamlined pathways for treated, stable mental health conditions.
For corporate and Part 91/135 operators, this issue matters both from a hiring perspective and a safety culture standpoint. Understanding that a stable, treated pilot on an approved SSRI is not inherently a greater risk than an untreated pilot silently struggling is critical for chief pilots and HR departments evaluating candidates with documented mental health histories. As more pilots share their certification journeys publicly—as seen in this thread—the aviation community continues to build a crowdsourced knowledge base that helps normalize treatment-seeking behavior and demystifies a process that has historically been shrouded in fear and misinformation, ultimately supporting both individual pilot careers and broader aviation safety.